CVS Health (CVS) Tops Q4 EPS by 1c, Reaffirms Outlook
Get Alerts CVS Hot Sheet
Price: $69.75 +1.50%
Revenue Growth %: +4.8%
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: +4.8%
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q4 EPS of $1.21, $0.01 better than the analyst estimate of $1.20. Revenue for the quarter came in at $37.1 billion versus the consensus estimate of $36.06 billion. Comps increased 1.6%.
2015 Guidance:
- Confirmed full year Adjusted EPS of $5.05 to $5.19; GAAP diluted EPS from continuing operations of $4.77 to $4.91
- Confirmed first quarter Adjusted EPS of $1.06 to $1.09; GAAP diluted EPS from continuing operations of $0.99 to $1.02
- Confirmed full year free cash flow of $5.9 to $6.2 billion; confirmed cash flow from operations of $7.6 to $7.9 billion
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Synovus Financial (SNV) PT Lowered to $42 at Piper Sandler
- Acme United (ACU) Misses Q1 EPS by 20c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Retail SalesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!